Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Xifaxan manufacturer?Rifampin 300 mg price?How much does prasugrel cost?Sagent pharmaceuticals doxorubicin hydrochloride?How does one manage lurbinectedin's adverse reactions?
See the DrugPatentWatch profile for verzenio
Verzenio (abemaciclib) was first approved by the FDA in 2017, which is when it began being available on the market in the US.[1]
From the 2017 FDA approval to 2026, Verzenio has been on the market for about 9 years.[1]
For branded cancer medicines, “time on the market” is usually tracked from the first regulatory approval date (not from later label expansions for additional indications). Verzenio’s initial FDA approval in 2017 is the reference point above.[1]
[1] https://www.drugpatentwatch.com/
Other Questions About Verzenio :